Corvus Pharmaceuticals (CRVS) Q1 2023 Earnings

8MayConfirmed
May 22
Aug 22
Nov 22
Q1 2023
-0.32
-0.26
-0.21
-0.15

Details

Expected EPS
-0.16
Actual EPS
-0.17
Surprise EPS
-0.01
Surprise Percent
+6.25%

Description

Corvus Pharmaceuticals (CRVS) has reported earnings of -0.17 per share for Q1 2023.

0 Comments

Share your thoughts